Dec 2025 $30 M No. 7 $10 to $50 million 1
Enable Injections, LLC: Raise no. 7, Dec 2025 × Investors in this round 1 investor had bought by the notice of Jan 9, 2026: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $30 M of $30 M offered
Smallest investment taken $1
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David D. Kroekel · Executive Officer Matt D. Huddleston · Executive Officer Michael D. Hooven · Executive Officer, Director Timothy Flaherty · Executive Officer Beckie J. Robertson · Director Erik D. Falk · Director Jim J. Collins · Director John J. DeFord · Director John J. Rice · Director Nigel J. Sheail · Director Richard J. D'Augustine · Director Simone D. Song · Director Vickie J. Capps · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Timothy Flaherty, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 9, 2026. Read the notice at the SEC .
equity SEC Jan 2022 $150 M No. 6 $50 to $250 million 22
Enable Injections, LLC: Raise no. 6, Jan 2022 × Investors in this round 22 investors had bought by the notice of Feb 3, 2022: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $150 M of $215 M offered; $65 M still to sell
Smallest investment taken $1
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $8,252,453
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Michael D. Hooven · Executive Officer, Director Timothy R. Flaherty · Executive Officer John J Rice · Director Karen J Robards · Director Norman R. Weldon · Director Richard J D'Augustine · Director Simone J Song · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round UBS Securities LLC · New York, New York Sold in CO, IL, NY, OH, TX Signed by Michael Hooven, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 3, 2022. Read the notice at the SEC .
equity, debt SEC Oct 2018 $31 M No. 5 $10 to $50 million 15
Enable Injections, LLC: Raise no. 5, Oct 2018 × Investors in this round 15 investors had bought by the notice of Oct 30, 2018: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $31 M of $50 M offered; $19 M still to sell
Smallest investment taken $1
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Michael D. Hooven · Executive Officer, Director Susan D. Spies · Executive Officer Timothy D. Flaherty · Executive Officer Daniel D. von Allmen · Director John D. Rice · Director Mark A. Collar · Director Norman D. Weldon · Director Richard D. D'Augustine · Director Simone A. Song · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Timothy Flaherty, Executive Vice President & Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 30, 2018. Read the notice at the SEC .
equity SEC Aug 2016 $25 M No. 4 $10 to $50 million 1
Enable Injections, LLC: Raise no. 4, Aug 2016 × Investors in this round 1 investor had bought by the notice of Nov 17, 2016: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $25 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Michael Hooven · Executive Officer Susan Spies · Executive Officer Timothy Flaherty · Executive Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Michael Hooven, President & CEO. Source: SEC Form D and 1 amendment, newest notice filed Nov 17, 2016. Read the notice at the SEC .
equity SEC Jun 2016 $5 M No. 3 $2 to $10 million 19
Enable Injections, LLC: Raise no. 3, Jun 2016 × Investors in this round 19 investors had bought by the notice of Aug 2, 2016: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Michael Hooven · Executive Officer Susan Spies · Executive Officer Timothy Flaherty · Executive Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Michael Hooven, President & CEO. Source: SEC Form D, newest notice filed Aug 2, 2016. Read the notice at the SEC .
equity SEC Sep 2014 $2 M No. 2 $2 to $10 million 13
Enable Injections, LLC: Raise no. 2, Sep 2014 × Investors in this round 13 investors had bought by the notice of Apr 18, 2016: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $5 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Michael Hooven · Executive Officer Susan Spies · Executive Officer Timothy Flaherty · Executive Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Timothy Flaherty, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 18, 2016. Read the notice at the SEC .
equity SEC May 2012 $2 M No. 1 $2 to $10 million 13
Enable Injections, LLC: Raise no. 1, May 2012 × Investors in this round 13 investors had bought by the notice of Aug 22, 2016: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken $25,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Michael Hooven · Executive Officer Susan Spies · Executive Officer Timothy Flaherty · Executive Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Michael Hooven, President & CEO. Source: SEC Form D, newest notice filed Aug 22, 2016. Read the notice at the SEC .
equity SEC